AI drug discovery company Earendil Labs and Genentech signed a $1.5 billion research collaboration to develop cancer therapies, the companies said Thursday.
Zoom out: The deal marks Earendil's latest collab with Big Pharma, following major autoimmune drug licensing deals with Sanofi.
